A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regimens for RO7656594 for subsequent studies.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent jest w ogólnie dobrym stanie zdrowia (może wykonywać codzienne czynności)
- •Rozpoznanie zaawansowanego raka prostaty, który rozprzestrzenił się na inne narządy
- •Wcześniejsze leczenie hormonalnymi lekami przeciwnowotworowymi (np. abiraterone, enzalutamide)
- •Wcześniejsze leczenie chemią (taksanami) lub pacjent nie może jej otrzymywać
- •W przypadku mutacji genu BRCA: wcześniejsze leczenie lekami PARP lub pacjent nie może ich otrzymywać
✗ Disqualifies
- •Stosowanie innego leczenia przeciwnowotworowego w ciągu ostatnich 14 dni
- •Uczestnictwo w innym badaniu klinicznym w ciągu ostatnich 28 dni
- •Wcześniejsze leczenie degraderami białka AR
- •Przerzuty do mózgu lub opon mózgowych, które nie były leczone
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (26)
HonorHealth
Scottsdale, United States
Yale Cancer Center
New Haven, United States
Sarah Cannon Research Institute @ Florida Cancer
Orlando, United States
University of Illinois Hospital & Health Sciences System
Chicago, United States
SCRI Oncology Partners
Nashville, United States
St Vincent's Hospital Sydney
Darlinghurst, Australia
Macquarie University Hospital
New South Wales, Australia
Monash Health Monash Medical Centre
Clayton, Australia
Austin Hospital
Heidelberg, Australia
British Columbia Cancer Agency
Vancouver, Canada
Princess Margaret Hospital
Toronto, Canada
Gustave Roussy
Villejuif, France
Centre Léon Bérard
Lyon, France
Institut Paoli Calmettes
Marseille, France
Seoul National University Hospital
Seoul, South Korea
Severance Hospital Yonsei University Health System - PPDS
Seoul, South Korea
Asan Medical Center - PPDS
Seoul, South Korea
Samsung Medical Center - PPDS
Seoul, South Korea
Clinica Universidad de Navarra
Pamplona, Spain
Hospital Universitario Vall d'Hebron - PPDS
Barcelona, Spain
Clinica Universidad de Navarra-Madrid
Madrid, Spain
Hospital Clinico San Carlos
Madrid, Spain
Cambridge Clinical Research Centre
Cambridge, United Kingdom
Leicester Royal Infirmary
Leicester, United Kingdom
The Christie
Manchester, United Kingdom
Royal Marsden Hospital - Surrey
Sutton, United Kingdom
Trial contact
GO44537 https://forpatients.roche.com/ No attachments to email below.
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.